- Home
- AVD vs FENC Comparison
AVD vs FENC Comparison
Compare AVD & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVD
- FENC
- Stock Information
- Founded
- AVD 1969
- FENC 1996
- Country
- AVD United States
- FENC United States
- Employees
- AVD N/A
- FENC N/A
- Industry
- AVD Agricultural Chemicals
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVD Industrials
- FENC Health Care
- Exchange
- AVD Nasdaq
- FENC Nasdaq
- Market Cap
- AVD 165.8M
- FENC 172.8M
- IPO Year
- AVD N/A
- FENC 2001
- Fundamental
- Price
- AVD $4.38
- FENC $5.92
- Analyst Decision
- AVD Strong Buy
- FENC Strong Buy
- Analyst Count
- AVD 3
- FENC 2
- Target Price
- AVD $16.67
- FENC $14.00
- AVG Volume (30 Days)
- AVD 296.0K
- FENC 165.5K
- Earning Date
- AVD 11-11-2024
- FENC 11-07-2024
- Dividend Yield
- AVD 2.03%
- FENC N/A
- EPS Growth
- AVD N/A
- FENC N/A
- EPS
- AVD N/A
- FENC N/A
- Revenue
- AVD $553,839,000.00
- FENC $49,348,000.00
- Revenue This Year
- AVD N/A
- FENC $97.94
- Revenue Next Year
- AVD $5.31
- FENC $11.50
- P/E Ratio
- AVD N/A
- FENC N/A
- Revenue Growth
- AVD N/A
- FENC 278.09
- 52 Week Low
- AVD $4.36
- FENC $3.96
- 52 Week High
- AVD $14.28
- FENC $11.92
- Technical
- Relative Strength Index (RSI)
- AVD 25.15
- FENC 54.12
- Support Level
- AVD $5.91
- FENC $5.51
- Resistance Level
- AVD $6.29
- FENC $6.17
- Average True Range (ATR)
- AVD 0.24
- FENC 0.37
- MACD
- AVD -0.16
- FENC -0.08
- Stochastic Oscillator
- AVD 5.77
- FENC 32.61
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.